The Giroir FDA: Acting Tenure Ending Soon – But It Was Eventful
Executive Summary
Brett Giroir’s tenure as acting commissioner of the US FDA won’t last long, but it has marked another high water mark in the pro-innovation climate at the agency, which is an important message about what FDA commissioners do – and don’t – actually do.